Assembly Biosciences, Inc. (NASDAQ:ASMB) is among the best growth stocks to invest in for the next 5 years. In the wake of ...

Cellectar Biosciences, Inc. (Nasdaq: CLRB) (the “Company”), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today ...

Is the day of the zombie biotech coming to an end? Eyes have it: Peninsula biotech focuses on glaucoma, more in big test Eyes ...

Learn about June 2025’s top biotech deals, featuring major collaborations in small molecules, protein therapeutics, and ...

Sophie Turner swapped her medieval kingdom for a cutting-edge adventure in biotech at this year’s SXSW London.

Breakthrough bioconvergence platform detects inflammatory events prior to symptoms, partnering with Altesa Biosciences to ...

AN Venture Partners has closed its first fund, a $200 million vault for biotechs worldwide, with particular emphasis on ...

Primo Biotechnology Secures A Funding and Targets 2026 IPO To enhance strengthen global radiopharmaceutical strategy and ...

With Terrana Biosciences, Moderna founder Flagship can apply its RNA knowledge to agricultural use cases like pest and disease resistance.

The company is hoping to become the next CSL, but stood its workforce down in November amid a cash crunch. A lifeline now ...

Nurix Therapeutics is subleasing 159,959 square feet of former Johnson & Johnson office space at 1600 Sierra Point Parkway in Brisbane, California. Johnson & Johnson closed the facility in February ...

Vyne Therapeutics has given up hopes of resuming a plaque psoriasis trial for its BET inhibitor placed on hold by the FDA, ...